Table 4.
Severity | Number of cases | Probable relevance to favipiravir | Cessation of favipiravir | Sequelae |
---|---|---|---|---|
Mild | 530 (20.9%a) | 245 (46.2%) | 1 (0.2%) | 0 (0%) |
Moderate | 202 (8.0%a) | 119 (58.9%) | 0 (0%) | 0 (0%) |
Serious | 3 (0.1%a) | 1 (33.3%) | 0 (0%) | 0 (0%) |
Mild: adverse events need no treatment or presented no symptom. Moderate: adverse events need noninvasive treatment. Serious: eminent adverse events need invasive treatment
aDenominators are the total number of cases treated with favipiravir (n = 2532)